Bayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited have concluded their joint venture, Bayer Zydus Pharma Private Limited...

The Organisation of Pharmaceutical Producers of India (OPPI) has appointed Anil Matai as its director general. Matai has extensive experien...

Adani Ports, Coal India, Siemens, Hindalco, Linde India, Lloyds Metals, Phoenix Mills, Oil India, Prestige Estates, Aarti Industries, Happi...

The drug, touted as a potential blockbuster drug for the German pharmaceutical firm, will be sold under the brand name Kerendia in India.

"The major focus of therapy in patients with chronic kidney disease and diabetes is to prevent end-stage renal disease or kidney failure. D...

"The spirit of partnership in this joint venture has all been about channelling the core strengths of both Zydus and Bayer for the benefit ...

Diabetic Macular Edema occurs when high blood sugar levels damage capillaries that leak fluid into the retina, resulting in swelling and bl...

"Asia Pacific is the fastest growing region for Bayer's pharmaceuticals sales globally. We are very interested and committed to India and a...

Bayer CropScience informed that the board appointed Pankaj Patel as an additional non-executive director of the company with effect from Ju...

In India, Bayer sells the product through its equal stake JV Bayer Zydus, formed with Ahmedabad-based Zydus Cadila.

Zydus Hospitals & Healthcare Research recently started its first hospital operations at Anand, better known as Amul's hometown.

Zydus Cadila has acquired 100% stake in Mumbai-based Biochem Pharmaceuticals for an undisclosed amount.

Bayer AG said it expects sales in India to double by 2015 and targets more than 60% increase in revenue from entire Asia during the period

Ahmedabad-based Zydus Cadila today said its consolidated net profit rose by 15.38 per cent to Rs 229.82 crore in the first quarter ended Ju...

Cadila Healthcare today said its consolidated net profit rose by 50.69 per cent to Rs 178.97 crore for the fourth quarter ended March 31, 2...

Cadila Healthcare has signed an agreement with Bayer HealthCare to set up 50:50 joint venture in the name of "Bayer Zydus Pharma" for the s...

Ahmedabad-based drugmaker Zydus Cadila is in talks with Bayer Schering Pharma AG to market the German firm’s products in Indian retail mark...